I

INNP-WS

Innocan Pharma

0.000.00%
Closed--

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

29.44M

13.66M

2.56M

196.00K

8.00K

Net Income

-1.83M

-4.70M

-3.76M

-10.05M

-9.95M

ROE

-0.3215

-0.8859

-0.4941

-3.7184

9.0729

ROA

-0.2264

-0.6755

-0.385

-1.1884

-2.8783

EPS

-0.4258

-1.1891

-0.9831

-2.9093

-3.9942

BVPS

1.158

0.9954

1.6647

2.3693

-1.2453

Asset Turnover

3.6342

1.9628

0.2618

0.0232

0.0023

Debt-to-Asset

0.2417

0.368

0.1077

0.2834

1.8323

Current Ratio

4.0871

2.6756

9.409

3.5132

0.5388

Quick Ratio

2.605

1.9886

7.8618

3.3701

0.4846